Benefits of M-16V Supplementation in Preterm Neonates A Retrospective Cohort Study.

2020-04-30 4391
Tags:

Main Research Contents:

To determine whether routine probiotic supplementation (RPS) to preterm neonates would reduce the incidence of NEC.

Main Research Findings:

RPS with Bifidobacterium breve M-16V was associated with decreased NEC≥ Stage II and ‘NEC≥ Stage II or all-cause mortality’ in neonates.

Patole S., et al.
Benefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates A Retrospective Cohort Study.
Article in PLoS ONE • March 2016
 

Back